operations, GAAP basis $62,439
Interest expense, net (2) 38,040
Income before taxes, pro-forma 24,399
Provision for income taxes, pro-forma 9,901
Net income, pro-forma 14,498
Earnings per share, pro-forma $0.49
Shares used to compute diluted per common share amounts,
for GAAP basis 21,981,026
Effects of dilutive options and restricted stock 695,942
Effects of conversion of Redeemable preferred 6,613,757
Shares used to compute diluted per common share amounts 29,290,725
Year Ended
December 31, 2006
Cash flow from operations, GAAP basis $24,037
Premium paid on extinguishment of debt (2) 11,866
Tax (cost) of debt extinguishment (6,558)
Cash flow from operations, pro-forma $29,345
(2) Assumes debt refinancing occurred effective January 1, 2006.
Hanger Orthopedic Group, Inc.
Three Months Ended Year Ended
Statistical Data: December 31, December 31,
2007 2006 2007 2006
Patient-care centers 636 618 636 618
Number of Practitioners 1,060 1,034 1,060 1,034
Number of states (including D.C.) 46 46 46 46
Payor mix:
Private pay and other 61.1% 59.7% 59
'/>"/>
SOURCE Hanger Orthopedic Group, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related medicine news :1.
Hanger Orthopedic Group, Inc. Announces Record Revenue of $162.3 Million and 20% Growth in Earnings Per Share for the Quarter Ended September 30, 20072.
Infor-Med, Inc. Announces New Praxis EMR Version 4 with The Praxis Knowledge Exchanger(R)3.
Hanger Orthopedic Group, Inc. Announces Three Acquisitions Totaling Over $3.5 Million of Annual Net Revenue4.
Hanger Orthopedic Group, Inc. Announces 2007 Year-End Earnings Release Conference Call5.
Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance6.
Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year7.
QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes8.
QED International Announces Changes to the HealthShares(TM) Orthopedic Repair Index9.
Orthopedic Surgeon Contributes Knowledge on Research and Treatment in Weekly Blogs on MyOsteoarthritisCentral.com10.
Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO11.
Ascension Orthopedics Launches the TITAN(TM) Humeral Resurfacing Device World Wide